Ligand Avinza Reimbursement Expected By PBMs Covering 150-200 Mil. Lives
Executive Summary
Ligand expects to enter agreements for the opioid Avinza with pharmacy benefit managers covering a total of 150 mil. to 200 mil. lives within the next several months, Ligand CEO Dave Robinson said during an Aug. 13 quarterly call